These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4084726)

  • 1. Oncogenes and bladder cancer.
    Malone PR; Visvanathan KV; Ponder BA; Shearer RJ; Summerhayes IC
    Br J Urol; 1985 Dec; 57(6):664-7. PubMed ID: 4084726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo amplification and rearrangement of the c-Ha-ras-1 sequence in a human bladder carcinoma.
    Hayashi K; Kakizoe T; Sugimura T
    Gan; 1983 Dec; 74(6):798-801. PubMed ID: 6667831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours.
    Fujita J; Yoshida O; Yuasa Y; Rhim JS; Hatanaka M; Aaronson SA
    Nature; 1984 May 31-Jun 6; 309(5967):464-6. PubMed ID: 6328318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of H-ras oncogene in rat bladder tumors induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Fujita J; Ohuchi N; Ito N; Reynolds SH; Yoshida O; Nakayama H; Kitamura Y
    J Natl Cancer Inst; 1988 Mar; 80(1):37-43. PubMed ID: 3276902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential hypomethylation of the c-myc protooncogene in bladder cancers at different stages and grades.
    Del Senno L; Maestri I; Piva R; Hanau S; Reggiani A; Romano A; Russo G
    J Urol; 1989 Jul; 142(1):146-9. PubMed ID: 2733094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ras gene alterations in invasive and non-invasive rat bladder carcinomas induced by N-methyl-N-nitrosourea.
    Yura Y; Azuma M; Uchida K; Momose H; Oyasu R
    Br J Cancer; 1991 Jul; 64(1):10-4. PubMed ID: 1854607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between the expression of oncogenes ras and c-erbB-2 and the biological behavior of bladder tumors.
    Ye DW; Zheng JF; Qian SX; Ma YJ
    Urol Res; 1993 Jan; 21(1):39-43. PubMed ID: 8096102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
    Coombs LM; Pigott DA; Sweeney E; Proctor AJ; Eydmann ME; Parkinson C; Knowles MA
    Br J Cancer; 1991 Apr; 63(4):601-8. PubMed ID: 1673627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential and novel activation of H-ras in human bladder carcinomas.
    Visvanathan KV; Pocock RD; Summerhayes IC
    Oncogene Res; 1988; 3(1):77-86. PubMed ID: 3144694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change.
    Taparowsky E; Suard Y; Fasano O; Shimizu K; Goldfarb M; Wigler M
    Nature; 1982 Dec; 300(5894):762-5. PubMed ID: 7177195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA, RNA and immunohistochemical characterization of the HER-2/neu oncogene in transitional cell carcinoma of the bladder.
    Wood DP; Wartinger DD; Reuter V; Cordon-Cardo C; Fair WR; Chaganti RS
    J Urol; 1991 Nov; 146(5):1398-401. PubMed ID: 1942310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-frequency mutation of Ha-ras and Ki-ras oncogenes in transitional cell carcinoma of the bladder.
    Olderøy G; Daehlin L; Ogreid D
    Anticancer Res; 1998; 18(4A):2675-8. PubMed ID: 9703927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of RAS family genes in urothelial carcinoma.
    Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA
    J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIAA1096, a gene on chromosome 1q, is amplified and overexpressed in bladder cancer.
    Huang WC; Taylor S; Nguyen TB; Tomaszewski JE; Libertino JA; Malkowicz SB; McGarvey TW
    DNA Cell Biol; 2002 Oct; 21(10):707-15. PubMed ID: 12443540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of Harvey-ras oncogene in FANFT-induced transitional cell carcinoma.
    Sawczuk IS; Walsh W; King W; Olsson CA; Nguyen-Huu C
    Urol Int; 1987; 42(5):321-5. PubMed ID: 3433577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of normal and mutated forms of HRAS induces orthotopic bladder invasion in a human transitional cell carcinoma.
    Theodorescu D; Cornil I; Fernandez BJ; Kerbel RS
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):9047-51. PubMed ID: 2247480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of H-ras mutations in human bladder cancer detected by direct sequencing.
    Burchill SA; Neal DE; Lunec J
    Br J Urol; 1994 May; 73(5):516-21. PubMed ID: 8012773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
    Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C
    J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer.
    Wood DP; Fair WR; Chaganti RS
    J Urol; 1992 Jan; 147(1):274-7. PubMed ID: 1729545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Her-2/neu protein overexpression and gene amplification in human transitional cell carcinoma of the bladder.
    Montie JE
    J Urol; 2005 Jun; 173(6):1921-2. PubMed ID: 15879779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.